You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 169 No. 11, June 8, 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Journalology/ Peer Review/ Authorship
 •Conflict of Interest
 •Cardiovascular System
 •Drug Therapy, Other
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Conflicts of Interest Need to Be Reported Reliably

Jeff Whittle, MD, MPH

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I was concerned to note that the Archives reported no financial conflicts of interest for Bertram Pitt, MD, in regard to his recent Invited Commentary1 to the article "Comparative Effectiveness of β-Blockers in Elderly Patients With Heart Failure."2

Dr Pitt's expertise in the area is obvious in his well reasoned and insightful commentary. However, it is clear that he has conflicts of interest in regard to the cardiovascular drugs in general and β-blockers in particular. For example, within the past month, he has disclosed his consulting relationship with Pfizer, Novartis, Takeda Pharmaceuticals North America, AstraZeneca, and Merck in the context of an article in the New England Journal of Medicine.3

The Archives has taken the principled position that an author's conflicts of interest should be disclosed to the reader. This seems especially important for editorials and invited commentaries. It is clear that Dr Pitt has . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Comparative Effectiveness of β-Blockers in Elderly Patients With Heart Failure—Invited Commentary
Bertram Pitt
Arch Intern Med. 2008;168(22):2431-2432.
EXTRACT | FULL TEXT  

RELATED LETTER

Conflicts of Interest Need to Be Reported Reliably—Reply
Bertram Pitt
Arch Intern Med. 2009;169(11):1079.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.